共 171 条
[1]
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase 1 findings, N Engl J Med, 312, pp. 932-936, (1985)
[2]
Hillis LD, Borer J, Braunwald E., Et al., High dose intravenous streptokinase for acute myocardial infarction: Preliminary results of a multicenter trial, JACC, 6, pp. 957-962, (1985)
[3]
Williams DO, Borer J, Braunwald E, Intravenous recombinant tissue‐type plasminogen activator in acute myocardial infarction: A report from the NHLBI thrombolysis in myocardial infarction trial, Circulation, 73, pp. 338-346, (1986)
[4]
Chesebro JH, Knatterud G, Roberts R, Et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase 1: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase, Circulation, 76, pp. 142-154, (1987)
[5]
Sheehan F, Braunwald E, Canner P, The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial, Circulation, 75, pp. 817-829, (1987)
[6]
Bennett WR, Yawn DH, Migliore PJ, Et al., Activation of the complement system by recombinant tissue plasminogen activator, JACC, 10, pp. 627-632, (1987)
[7]
Gore JM, Roberts R, Ball SP, Et al., Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction, Am J Cardiol, 59, pp. 1234-1238, (1987)
[8]
Dalen JE, Gore JM, Braunwald E, Et al., Six‐ and twelve‐month follow‐up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial, Am J Cardiol, 62, pp. 179-185, (1988)
[9]
Held AC, Gore JM, Paraskos LA, Et al., Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction, Am J Cardiol, 62, pp. 310-311, (1988)
[10]
Holmes JD.R., Bove AA, Nishimura RA, Et al., Comparison of monoplane and biplane assessment of regional left ventricular wall motion after thrombolytic therapy for acute myocardial infarction, Am J Cardiol, 59, pp. 793-797, (1987)